Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

  • This share is currently suspended. It was suspended at a price of 470.00

Share Price Information for Dunedin Ent.it. (DNE)

Share Price is delayed by 15 minutes
Get Live Data
470.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
DNE Live PriceLast checked at - London Stock Exchange

Intraday Dunedin Ent.it. Share Chart

Interim Management Statement

13 Nov 2009 09:18

RNS Number : 4719C
Dunedin Enterprise Inv Trust PLC
13 November 2009
 

Dunedin Enterprise Investment Trust PLC (Company No SC52844) - Interim Management

Statement

Dunedin Enterprise Investment Trust PLC ("Dunedin Enterprise") presents its Interim Management Statement for the quarter ended 30 September 2009. This is the Company's second interim management statement for the financial year ending 31 December 2009, as required by the FSA Disclosure and Transparency Rule 4.3.

1. Investment Objective

Dunedin Enterprise specialises in the provision of private equity finance. Private equity is medium to long term finance provided in return for an equity stake in established, potentially high growth private companies. The Company's investment objective is to achieve substantial long term capital growth in its assets through capital gains from its investments.

2. Unaudited net asset value per share

The unaudited net asset value per share at 30 September 2009 was 404.6p. This represents a fall of 0.9% from the level at 30 June 2009. 

3. Share price and discount

The share price rose by 9.5% from 283p to 309.8p in the quarter to 30 September 2009. This compares to a rise in the FTSE Small Cap Index of 34.0% over the same period.

Based upon the net asset value per share of 404.6p, the discount of the share price to the net asset value per share decreased from 30.7% to 23.4% in the quarter. When cash is excluded from net assets then the discount increases to 48.8%.

The share price at the close of business on 13 November 2009 was 297p, which was 4.1% lower than at 30 September 2009. The share price of 297p represents a discount of 26.6% to the net asset value per share of 404.6p and when cash is excluded from net assets then the discount increases to 55.4%.

4. Balance Sheet

 

The balance sheet as at 30 September 2009 is noted below:-

ÂŁm Dunedin managed 31.4Third party managed 6.8Listed private equity 26.8Legacy technology funds 2.5Total investments 67.5 Cash and near cash 63.4Other assets/liabilities (8.8)Total net assets 122.1 Net asset value per share (p) 404.6

 

5. Valuations

The portfolio of investments has been revalued at 30 September 2009. The most significant movements in net asset during the quarter were a result of:-

an increase in the value of Euro listed private equity of ÂŁ3.3m,

a reduction in net assets caused by a movement in the value of the Euro hedge instrument of ÂŁ3.7m,

payment of the interim dividend -ÂŁ0.2m, and

other portfolio movements of -ÂŁ0.5m.

6. Commitments

As at 30 September 2009 the Company has outstanding capital commitments to limited partnership funds of ÂŁ112.5m. In addition to cash and near cash balances of ÂŁ63.4m at 30 September 2009 the Company has listed private equity of ÂŁ26.8m and an undrawn bank borrowing facility of ÂŁ39m.

7. Hedging

The Company's hedging arrangements were closed out on 9 October 2009 and to date have not been replaced.

8. Outlook

The market remains challenging and our efforts remain focused on protecting value in the portfolio. There are however some encouraging signs of increased activity in new business opportunities.

For further information on Dunedin Enterprise please go to www.dunedin.com

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGCBDBUBBGGCX
Date   Source Headline
29th Jan 20251:17 pmRNSStatement re First Distribution in Liquidation
6th Jan 20252:48 pmRNSResult of General Meeting
30th Dec 20245:30 pmRNSDunedin Enterprise Investment Trust
19th Dec 20243:38 pmRNSGM - Announcement of Suspension Timetable
19th Dec 20243:27 pmRNSGM - Announcement of Suspension Timetable
9th Dec 20247:00 amRNSHolding(s) in Company
4th Dec 202410:00 amRNSGeneral Meeting re: Member's Voluntary Liquidation
4th Dec 202410:00 amRNSPublication of Circular and Winding-up Timetable
3rd Dec 20248:44 amRNSGeneral Meeting re: Member's Voluntary Liquidation
29th Nov 20241:38 pmRNSPortfolio Update
1st Nov 20247:00 amRNSPreliminary Unaudited Net Asset Value at 30/09/24
11th Sep 20247:00 amRNSHalf-year Report
27th Aug 20247:00 amRNSDividend Declaration
5th Aug 20247:00 amRNSPortfolio Update
1st Aug 20247:00 amRNSPreliminary unaudited net asset value at 30/6/24
15th May 20241:17 pmRNS1st Quarter Results
15th May 20241:12 pmRNSResult of AGM
7th May 20245:37 pmRNSHolding(s) in Company
1st May 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/3/24
22nd Mar 20247:00 amRNSAnnual Financial Report
5th Feb 20241:58 pmRNSHolding(s) in Company
5th Feb 20241:56 pmRNSHolding(s) in Company
5th Feb 20241:54 pmRNSHolding(s) in Company
1st Feb 20247:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/23
19th Dec 20232:34 pmRNSHolding(s) in Company
19th Dec 20232:22 pmRNSHolding(s) in Company
13th Dec 20237:00 amRNSDividend Declaration
21st Nov 20237:00 amRNSPremier Hytemp realisation & potential winding-up
16th Nov 20237:00 amRNS3rd Quarter Results
6th Nov 20234:33 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSPortfolio Update
1st Nov 20237:00 amRNSPreliminary Unaudited Net Asset Value at 30/9/23
28th Sep 20237:00 amRNSPortfolio Update
15th Sep 20237:00 amRNSHalf-year Report
1st Aug 20237:00 amRNSPreliminary unaudited net asset value at 30/6/23
6th Jun 20239:01 amRNSHolding(s) in Company
22nd May 202310:05 amRNSHolding(s) in Company
10th May 20232:42 pmRNSResult of AGM
10th May 20232:42 pmRNS1st Quarter Results
2nd May 20237:00 amRNSPreliminary unaudited net asset value at 31/3/23
24th Mar 20237:00 amRNSAnnual Financial Report
1st Feb 20237:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/22
7th Dec 20221:02 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
7th Dec 20221:00 pmRNSDirector/PDMR Shareholding
6th Dec 202211:12 amRNSDirector/PDMR Shareholding
6th Dec 202211:09 amRNSDirector/PDMR Shareholding
1st Dec 202212:42 pmRNSHolding(s) in Company
30th Nov 20225:50 pmRNSDirector/PDMR Shareholding
30th Nov 20225:48 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.